ABCB1 identifies a subpopulation of uveal melanoma cells with high metastatic propensity

Pigment Cell and Melanoma Research

Volumn 24, Issue 3, 2011, Pages 430-437

  Landreville, Solange ^a,b   Agapova, Olga A ^a   Kneass, Zachary T ^a   Salesse, Christian ^b   William Harbour, J ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITÉ LAVAL   (Canada)

Author keywords

ABCB1; Immunodeficient mouse model; Metastasis; Mitochondrial respiration; Uveal melanoma

Indexed keywords

MULTIDRUG RESISTANCE PROTEIN 1;

ANCHORAGE INDEPENDENT GROWTH; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CARCINOGENICITY; CELL MIGRATION; CELL SUBPOPULATION; CLONOGENESIS; CONTROLLED STUDY; HUMAN; HUMAN CELL; MELANOMA CELL; METASTASIS; MITOCHONDRIAL RESPIRATION; MOUSE; NONHUMAN; PROTEIN EXPRESSION; TUMOR CELL; UVEA MELANOMA;

ANIMALS; CELL LINE, TUMOR; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MELANOMA; MICE; MICE, KNOCKOUT; NEOPLASM METASTASIS; NEOPLASM PROTEINS; P-GLYCOPROTEIN; UVEAL NEOPLASMS;

EID: 79956019222     PISSN: 17551471     EISSN: 1755148X     Source Type: Journal    
DOI: 10.1111/j.1755-148X.2011.00841.x     Document Type: Article

References (25)

1. Boiko, A. D., Razorenova, O. V., van de Rijn, M. et al. (2010). Human melanoma-initiating cells express neural crest nerve growth factor receptor CD271. Nature 466, 133-137.
2. Boonyaratanakornkit, J.B., Yue, L., Strachan, L.R., Scalapino, K.J., LeBoit, P.E., Lu, Y., Leong, S.P., Smith, J.E., and Ghadially, R. (2010). Selection of tumorigenic melanoma cells using ALDH. J. Invest. Dermatol. 130, 2799-2808.
3. Chang, S.H., Worley, L.A., Onken, M.D., and Harbour, J.W. (2008). Prognostic biomarkers in uveal melanoma: evidence for a stem cell-like phenotype associated with metastasis. Melanoma Res. 18, 191-200.
4. Dunne, B.M., McNamara, M., Clynes, M., Shering, S.G., Larkin, A.M., Moran, E., Barnes, C., and Kennedy, S.M. (1998). MDR1 expression is associated with adverse survival in melanoma of the uveal tract. Hum. Pathol. 29, 594-598.
5. Finger, P.T. (2009). The 7th edition AJCC staging system for eye cancer: an international language for ophthalmic oncology. Arch. Pathol. Lab. Med. 133, 1197-1198.
6. Fukunaga-Kalabis, M., Martinez, G., Nguyen, T.K., Kim, D., Santiago-Walker, A., Roesch, A., and Herlyn, M. (2010). Tenascin-C promotes melanoma progression by maintaining the ABCB5-positive side population. Oncogene 29, 6115-6124.
7. Gutova, M., Najbauer, J., Gevorgyan, A., Metz, M.Z., Weng, Y., Shih, C.C., and Aboody, K.S. (2007). Identification of uPAR-positive chemoresistant cells in small cell lung cancer. PLoS ONE 2, e243.
8. Haraguchi, N., Utsunomiya, T., Inoue, H., Tanaka, F., Mimori, K., Barnard, G.F., and Mori, M. (2006). Characterization of a side population of cancer cells from human gastrointestinal system. Stem Cells 24, 506-513.
9. Harbour, J.W. (2003). Clinical overview of uveal melanoma: introduction to tumors of the eye. In Ocular Oncology, D.M., Albert, and A., Polans, eds. (New York: Marcel Dekker), pp. 1-18.
10. Harbour, J.W., Onken, M.D., Roberson, E.D. et al. (2010). Frequent mutation of BAP1 in metastasizing uveal melanomas. Science 330, 1410-1413.
11. Helczynska, K., Kronblad, A., Jogi, A., Nilsson, E., Beckman, S., Landberg, G., and Pahlman, S. (2003). Hypoxia promotes a dedifferentiated phenotype in ductal breast carcinoma in situ. Cancer Res. 63, 1441-1444.
12. Hendrix, M.J., Seftor, E.A., Hess, A.R., and Seftor, R.E. (2003). Vasculogenic mimicry and tumour-cell plasticity: lessons from melanoma. Nat. Rev. Cancer 3, 411-421.
13. Kartner, N., Riordan, J.R., and Ling, V. (1983). Cell surface P-glycoprotein associated with multidrug resistance in mammalian cell lines. Science 221, 1285-1288.
14. Keshet, G.I., Goldstein, I., Itzhaki, O. et al. (2008). MDR1 expression identifies human melanoma stem cells. Biochem. Biophys. Res. Commun. 368, 930-936.
15. Lofstedt, T., Jogi, A., Sigvardsson, M., Gradin, K., Poellinger, L., Pahlman, S., and Axelson, H. (2004). Induction of ID2 expression by hypoxia-inducible factor-1: a role in dedifferentiation of hypoxic neuroblastoma cells. J. Biol. Chem. 279, 39223-39231.
16. Monzani, E., Facchetti, F., Galmozzi, E. et al. (2007). Melanoma contains CD133 and ABCG2 positive cells with enhanced tumourigenic potential. Eur. J. Cancer 43, 935-946.
17. Onken, M.D., Worley, L.A., Ehlers, J.P., and Harbour, J.W. (2004). Gene expression profiling in uveal melanoma reveals two molecular classes and predicts metastatic death. Cancer Res. 64, 7205-7209.
18. Onken, M.D., Ehlers, J.P., Worley, L.A., Makita, J., Yokota, Y., and Harbour, J.W. (2006). Functional gene expression analysis uncovers phenotypic switch in aggressive uveal melanomas. Cancer Res. 66, 4602-4609.
19. Quintana, E., Shackleton, M., Foster, H.R., Fullen, D.R., Sabel, M.S., Johnson, T.M., and Morrison, S.J. (2010). Phenotypic heterogeneity among tumorigenic melanoma cells from patients that is reversible and not hierarchically organized. Cancer Cell 18, 510-523.
20. Rappa, G., Fodstad, O., and Lorico, A. (2008). The stem cell-associated antigen CD133 (Prominin-1) is a molecular therapeutic target for metastatic melanoma. Stem Cells 26, 3008-3017.
21. Refaeli, Y., Bhoumik, A., Roop, D.R., and Ronai, Z.A. (2009). Melanoma-initiating cells: a compass needed. EMBO Rep. 10, 965-972.
22. Roesch, A., Fukunaga-Kalabis, M., Schmidt, E.C. et al. (2010). A temporarily distinct subpopulation of slow-cycling melanoma cells is required for continuous tumor growth. Cell 141, 583-594.
23. Schatton, T., Murphy, G.F., Frank, N.Y. et al. (2008). Identification of cells initiating human melanomas. Nature 451, 345-349.
24. Visvader, J.E., and Lindeman, G.J. (2008). Cancer stem cells in solid tumours: accumulating evidence and unresolved questions. Nat. Rev. Cancer 8, 755-768.
25. Zhou, S., Schuetz, J.D., Bunting, K.D. et al. (2001). The ABC transporter Bcrp1/ABCG2 is expressed in a wide variety of stem cells and is a molecular determinant of the side-population phenotype. Nat. Med. 7, 1028-1034.